JP Morgan Chase
AZN icon

JP Morgan Chase’s AstraZeneca AZN Stock Holding History

JP Morgan Chase’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12M Buy
+62,000
New +$12M ﹤0.01% 2508
2025
Q2 		– Sell
-33,100
Closed -$4.87M – 7069
2025
Q1 		$4.87M Sell
33,100
-46,650
-58% -$6.75M ﹤0.01% 3186
2024
Q4 		$10.5M Buy
79,750
+49,750
+166% +$6.96M ﹤0.01% 2650
2024
Q3 		$4.67M Sell
30,000
-22,550
-43% -$3.64M ﹤0.01% 3266
2024
Q2 		$8.2M Buy
52,550
+22,550
+75% +$3.39M ﹤0.01% 2630
2024
Q1 		$4.07M Hold
30,000
– – ﹤0.01% 3274
2023
Q4 		$4.04M Sell
30,000
-28,500
-49% -$3.7M ﹤0.01% 3276
2023
Q3 		$7.92M Sell
58,500
-28,550
-33% -$3.9M ﹤0.01% 2461
2023
Q2 		$12.5M Buy
+87,050
New +$12.8M ﹤0.01% 2097
2022
Q1 		– Sell
-67,946
Closed -$7.92M – 6582
2021
Q4 		$7.92M Hold
67,946
– – ﹤0.01% 2657
2021
Q3 		$8.16M Buy
+67,946
New +$7.91M ﹤0.01% 2579
2021
Q1 		– Sell
-58,750
Closed -$5.87M – 6058
2020
Q4 		$5.87M Buy
58,750
+40,000
+213% +$4.24M ﹤0.01% 2667
2020
Q3 		$2.07M Hold
18,750
– – ﹤0.01% 3210
2020
Q2 		$1.98M Hold
18,750
– – ﹤0.01% 3106
2020
Q1 		$1.68M Hold
18,750
– – ﹤0.01% 3084
2019
Q4 		$1.87M Buy
+18,750
New +$1.77M ﹤0.01% 3430
2019
Q3 		– Sell
-23,700
Closed -$1.94M – 5713
2019
Q2 		$1.94M Buy
+23,700
New +$1.86M ﹤0.01% 3400
2015
Q1 		– Sell
-1,074,800
Closed -$75.6M – 4059
2014
Q4 		$75.6M Buy
+1,074,800
New +$77M 0.02% 739

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

JP Morgan Chase's AZN Position: Q1 2026 in Review

JP Morgan Chase increased its AstraZeneca (AZN) stake by 892% in Q1 2026, buying an estimated $3.22B and bringing the position to 18,590,922 shares worth $3.6B. The position accounts for 0.23% of the portfolio, ranked #95.

JP Morgan Chase first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • JP Morgan Chase held 18,590,922 shares of AstraZeneca worth $3.6B as of Q1 2026.
  • JP Morgan Chase bought 16,717,429 AstraZeneca shares in Q1 2026, an estimated $3.22B.
  • AstraZeneca made up 0.23% of JP Morgan Chase's portfolio in Q1 2026, its #95 holding.
  • JP Morgan Chase first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.